Prevalence of Barrett's esophagus in asymptomatic individuals - PubMed (original) (raw)
Prevalence of Barrett's esophagus in asymptomatic individuals
Lauren B Gerson et al. Gastroenterology. 2002 Aug.
Abstract
Background & aims: The incidence of esophageal adenocarcinoma in the western world has been linked to chronic heartburn, regurgitation, and the development of the premalignant epithelium of Barrett's esophagus (BE). However, up to 40% of esophageal adenocarcinomas occur in patients without prior reflux symptoms. We prospectively screened for the presence of BE in asymptomatic subjects older than 50 years of age undergoing screening sigmoidoscopy for colorectal cancer.
Methods: Subjects undergoing sigmoidoscopy for colorectal cancer (CRC) screening were invited to undergo upper endoscopy. Exclusion criteria included symptoms of gastroesophageal reflux disease (GERD) more than once a month, use of medications for GERD, or previous endoscopy. BE was classified as long-segment BE (LSBE), short-segment BE (SSBE), and microscopic specialized intestinal metaplasia of the esophagogastric junction (SIM-EGJ).
Results: Of 408 potential study candidates, 110 subjects were screened; 9 were women. The mean (+/-SD) age was 61 +/- 9.3 (range, 50-80) years, most of them (73%) Caucasian. Intestinal metaplasia (IM) extending above the EGJ was detected in 27 (25%) subjects; 8 (7%) had LSBE, and 19 (17%) had SSBE. Patients with BE were no more likely to be obese, consumers of tobacco or alcohol, report a family history of GERD, show association with toxic exposure, or use antacids more than once a month, compared with those without BE.
Conclusions: BE was detected in 25% of asymptomatic male veterans older than 50 years of age undergoing screening sigmoidoscopy for CRC.
Comment in
- Is there a "Barrett's iceberg?".
Shaheen N. Shaheen N. Gastroenterology. 2002 Aug;123(2):636-9. doi: 10.1053/gast.2002.35134. Gastroenterology. 2002. PMID: 12145816 No abstract available.
Similar articles
- Trends in incidence and prevalence of specialized intestinal metaplasia, barrett's esophagus, and adenocarcinoma of the gastroesophageal junction.
Pera M. Pera M. World J Surg. 2003 Sep;27(9):999-1008; discussion 1006-8. doi: 10.1007/s00268-003-7052-2. Epub 2003 Aug 18. World J Surg. 2003. PMID: 12917764 Review. - Specialized intestinal metaplasia, dysplasia, and cancer of the esophagus and esophagogastric junction: prevalence and clinical data.
Hirota WK, Loughney TM, Lazas DJ, Maydonovitch CL, Rholl V, Wong RK. Hirota WK, et al. Gastroenterology. 1999 Feb;116(2):277-85. doi: 10.1016/s0016-5085(99)70123-x. Gastroenterology. 1999. PMID: 9922307 - The frequency of Barrett's esophagus in high-risk patients with chronic GERD.
Westhoff B, Brotze S, Weston A, McElhinney C, Cherian R, Mayo MS, Smith HJ, Sharma P. Westhoff B, et al. Gastrointest Endosc. 2005 Feb;61(2):226-31. doi: 10.1016/s0016-5107(04)02589-1. Gastrointest Endosc. 2005. PMID: 15729230 - Clinical, endoscopic, and functional studies in 408 patients with Barrett's esophagus, compared to 174 cases of intestinal metaplasia of the cardia.
Csendes A, Smok G, Quiroz J, Burdiles P, Rojas J, Castro C, HenrĂquez A. Csendes A, et al. Am J Gastroenterol. 2002 Mar;97(3):554-60. doi: 10.1111/j.1572-0241.2002.05529.x. Am J Gastroenterol. 2002. PMID: 11922546 - Barrett's esophagus and risk of esophageal adenocarcinoma.
Cossentino MJ, Wong RK. Cossentino MJ, et al. Semin Gastrointest Dis. 2003 Jul;14(3):128-35. Semin Gastrointest Dis. 2003. PMID: 14653412 Review.
Cited by
- Comparative Cost Effectiveness of Reflux-Based and Reflux-Independent Strategies for Barrett's Esophagus Screening.
Sami SS, Moriarty JP, Rosedahl JK, Borah BJ, Katzka DA, Wang KK, Kisiel JB, Ragunath K, Rubenstein JH, Iyer PG. Sami SS, et al. Am J Gastroenterol. 2021 Aug 1;116(8):1620-1631. doi: 10.14309/ajg.0000000000001336. Am J Gastroenterol. 2021. PMID: 34131096 Free PMC article. - Videoendoscopy and histopathology of the esophagogastric junction in patients with gastroesophageal reflux disease.
Ringhofer C, Lenglinger J, Eisler M, Wrba F, Sedivy R, Zacherl J, Cosentini EP, Prager G, Devyatko E, Riegler M. Ringhofer C, et al. Wien Klin Wochenschr. 2007;119(9-10):283-90. doi: 10.1007/s00508-007-0786-3. Wien Klin Wochenschr. 2007. PMID: 17571232 - Barrett's esophagus.
Peters JH, Hagen JA, DeMeester SR. Peters JH, et al. J Gastrointest Surg. 2004 Jan;8(1):1-17. doi: 10.1016/s1091-255x(03)00136-7. J Gastrointest Surg. 2004. PMID: 14746830 Review. No abstract available. - The prevalence of Barrett's esophagus in the US: estimates from a simulation model confirmed by SEER data.
Hayeck TJ, Kong CY, Spechler SJ, Gazelle GS, Hur C. Hayeck TJ, et al. Dis Esophagus. 2010 Aug;23(6):451-7. doi: 10.1111/j.1442-2050.2010.01054.x. Epub 2010 Mar 26. Dis Esophagus. 2010. PMID: 20353441 Free PMC article. - Undetected Barrett's esophagus: how do we improve early detection?
Loomans-Kropp HA, Richmond E. Loomans-Kropp HA, et al. Oncotarget. 2021 Nov 23;12(24):2418-2420. doi: 10.18632/oncotarget.28005. eCollection 2021 Nov 23. Oncotarget. 2021. PMID: 34853662 Free PMC article. No abstract available.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources